| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.522 | 0.004 | 0.591 | Phosphatidylinositol 3-kinase beta inhibitor | 0.489 0.004 DBMET03730 0.591 0.003 DBMET03731 0.378 0.004 DBMET03732 0.303 0.004 DBMET03733 0.437 0.004 DBMET03734 0.382 0.004 DBMET03735 | DBMET03731 | |
| 0.37 | 0.047 | 0.372 | Nootropic | 0.372 0.047 DBMET03730 0.348 0.055 DBMET03731 0.268 0.093 DBMET03732 0.288 0.08 DBMET03734 0.241 0.116 DBMET03735 | DBMET03730 | |
| 0.247 | 0.006 | 0.344 | Phosphatidylinositol kinase inhibitor | 0.344 0.005 DBMET03730 0.275 0.005 DBMET03731 0.13 0.014 DBMET03732 0.096 0.022 DBMET03733 0.157 0.011 DBMET03734 0.118 0.017 DBMET03735 | DBMET03730 | |
| 0.269 | 0.043 | 0.269 | ErbB-1 antagonist | 0.234 0.06 DBMET03730 | ||
| 0.253 | 0.047 | 0.268 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.238 0.052 DBMET03730 0.268 0.042 DBMET03731 0.161 0.087 DBMET03732 0.25 0.048 DBMET03734 0.136 0.108 DBMET03735 | DBMET03731 | |
| 0.198 | 0.006 | 0.2 | mTOR complex 1 inhibitor | 0.2 0.006 DBMET03730 0.2 0.006 DBMET03731 0.149 0.011 DBMET03732 0.13 0.019 DBMET03733 0.172 0.008 DBMET03734 0.144 0.013 DBMET03735 | DBMET03731 | |
| 0.192 | 0.008 | 0.206 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.165 0.009 DBMET03730 0.206 0.007 DBMET03731 0.1 0.016 DBMET03732 0.076 0.023 DBMET03733 0.12 0.013 DBMET03734 0.083 0.021 DBMET03735 | DBMET03731 | |
| 0.24 | 0.056 | 0.331 | Platelet aggregation inhibitor | 0.247 0.053 DBMET03730 0.146 0.134 DBMET03731 0.218 0.069 DBMET03732 0.147 0.132 DBMET03733 0.275 0.042 DBMET03734 0.331 0.029 DBMET03735 | DBMET03735 | |
| 0.201 | 0.026 | 0.201 | Platelet activating factor antagonist | 0.169 0.036 DBMET03730 0.127 0.058 DBMET03731 0.139 0.051 DBMET03732 0.104 0.075 DBMET03733 0.198 0.027 DBMET03734 0.12 0.063 DBMET03735 | ||
| 0.199 | 0.025 | 0.199 | Platelet activating factor beta antagonist | 0.153 0.037 DBMET03730 0.145 0.04 DBMET03731 0.132 0.044 DBMET03732 0.096 0.065 DBMET03733 0.191 0.027 DBMET03734 0.118 0.051 DBMET03735 | ||
| 0.197 | 0.037 | 0.308 | Insulin secretagoues | 0.171 0.054 DBMET03730 0.276 0.015 DBMET03731 0.255 0.019 DBMET03732 0.148 0.076 DBMET03733 0.284 0.014 DBMET03734 0.308 0.012 DBMET03735 | DBMET03735 | |
| 0.187 | 0.043 | 0.198 | Ribosomal protein S6 kinase inhibitor | 0.143 0.07 DBMET03730 0.198 0.038 DBMET03731 0.149 0.065 DBMET03732 0.125 0.085 DBMET03733 0.172 0.051 DBMET03734 0.122 0.088 DBMET03735 | DBMET03731 | |
| 0.209 | 0.066 | 0.209 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.177 0.098 DBMET03730 0.194 0.078 DBMET03731 0.185 0.088 DBMET03732 0.152 0.13 DBMET03733 0.175 0.1 DBMET03734 0.153 0.128 DBMET03735 | ||
| 0.198 | 0.055 | 0.198 | Src kinase inhibitor | 0.158 0.078 DBMET03730 0.178 0.066 DBMET03731 0.143 0.088 DBMET03732 0.144 0.088 DBMET03734 0.115 0.113 DBMET03735 | ||
| 0.188 | 0.046 | 0.191 | Lck kinase inhibitor | 0.151 0.065 DBMET03730 0.191 0.045 DBMET03731 0.15 0.065 DBMET03732 0.118 0.087 DBMET03733 0.156 0.062 DBMET03734 0.123 0.083 DBMET03735 | DBMET03731 | |
| 0.129 | 0.026 | 0.129 | Platelet growth factor antagonist | 0.108 0.036 DBMET03730 0.11 0.035 DBMET03731 0.104 0.038 DBMET03732 0.083 0.054 DBMET03733 0.118 0.031 DBMET03734 0.101 0.04 DBMET03735 | ||
| 0.157 | 0.057 | 0.178 | Cytokine production inhibitor | 0.178 0.045 DBMET03730 0.131 0.078 DBMET03731 0.124 0.086 DBMET03732 0.142 0.069 DBMET03733 0.129 0.08 DBMET03734 0.145 0.066 DBMET03735 | DBMET03730 | |
| 0.174 | 0.078 | 0.174 | Tyrosine kinase inhibitor | 0.14 0.095 DBMET03730 0.133 0.099 DBMET03731 | ||
| 0.294 | 0.2 | 0.443 | Caspase 9 stimulant | 0.443 0.087 DBMET03731 0.333 0.16 DBMET03732 0.29 0.205 DBMET03733 0.335 0.158 DBMET03734 0.375 0.127 DBMET03735 | DBMET03731 | |
| 0.115 | 0.023 | 0.115 | Adenosine A2 receptor antagonist | 0.058 0.05 DBMET03730 0.105 0.026 DBMET03731 0.059 0.049 DBMET03734 | ||
| 0.101 | 0.017 | 0.101 | Tyrosine-protein kinase EMT inhibitor | 0.093 0.02 DBMET03730 0.074 0.028 DBMET03731 0.054 0.043 DBMET03732 0.059 0.039 DBMET03734 | ||
| 0.106 | 0.024 | 0.106 | Adenosine A2a receptor antagonist | 0.096 0.026 DBMET03731 0.054 0.05 DBMET03734 | ||
| 0.115 | 0.033 | 0.115 | Toll-Like receptor 3 antagonist | 0.097 0.056 DBMET03730 0.093 0.062 DBMET03732 0.102 0.048 DBMET03734 0.094 0.061 DBMET03735 | ||
| 0.144 | 0.067 | 0.144 | Toll-Like receptor 9 antagonist | |||
| 0.133 | 0.06 | 0.133 | Epidermal growth factor receptor kinase inhibitor | 0.129 0.064 DBMET03730 0.101 0.097 DBMET03731 0.102 0.094 DBMET03734 | ||
| 0.135 | 0.074 | 0.158 | Protein-tyrosine kinase Lyn inhibitor | 0.158 0.062 DBMET03731 0.107 0.096 DBMET03732 0.113 0.09 DBMET03734 | DBMET03731 | |
| 0.106 | 0.045 | 0.106 | Interleukin 12 antagonist | 0.091 0.07 DBMET03730 | ||
| 0.08 | 0.02 | 0.161 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.161 0.008 DBMET03730 0.085 0.018 DBMET03731 0.055 0.037 DBMET03732 0.055 0.038 DBMET03734 | DBMET03730 | |
| 0.1 | 0.04 | 0.1 | AXL receptor tyrosine kinase inhibitor | 0.088 0.051 DBMET03730 | ||
| 0.096 | 0.036 | 0.096 | Phosphodiesterase XI inhibitor | 0.092 0.04 DBMET03730 0.084 0.051 DBMET03731 0.082 0.054 DBMET03734 | ||
| 0.096 | 0.036 | 0.096 | Phosphodiesterase 11A inhibitor | 0.092 0.04 DBMET03730 0.084 0.051 DBMET03731 0.082 0.054 DBMET03734 | ||
| 0.217 | 0.158 | 0.217 | Ca(v)3.3 blocker | 0.203 0.185 DBMET03732 | ||
| 0.209 | 0.153 | 0.237 | Immunomodulator | 0.208 0.155 DBMET03731 0.233 0.129 DBMET03732 0.237 0.126 DBMET03734 0.201 0.163 DBMET03735 | DBMET03734 | |
| 0.059 | 0.005 | 0.059 | ATM kinase inhibitor | 0.055 0.006 DBMET03730 0.035 0.028 DBMET03731 0.048 0.009 DBMET03732 0.04 0.018 DBMET03733 0.038 0.022 DBMET03734 0.035 0.029 DBMET03735 | ||
| 0.149 | 0.096 | 0.174 | Antipruritic | 0.174 0.07 DBMET03731 0.168 0.076 DBMET03732 0.153 0.091 DBMET03734 0.138 0.11 DBMET03735 | DBMET03731 | |
| 0.062 | 0.014 | 0.062 | DNA-dependent protein kinase inhibitor | 0.054 0.019 DBMET03730 0.045 0.025 DBMET03731 | ||
| 0.055 | 0.011 | 0.065 | Alpha 1L adrenoreceptor agonist | 0.052 0.015 DBMET03730 0.065 0.006 DBMET03731 0.05 0.016 DBMET03732 0.047 0.02 DBMET03733 0.056 0.011 DBMET03734 0.054 0.013 DBMET03735 | DBMET03731 | |
| 0.122 | 0.082 | 0.181 | Interleukin 4 antagonist | 0.181 0.029 DBMET03731 0.129 0.074 DBMET03732 0.153 0.047 DBMET03734 0.149 0.051 DBMET03735 | DBMET03731 | |
| 0.097 | 0.057 | 0.097 | Antihistaminic | |||
| 0.097 | 0.058 | 0.131 | Antiadrenergic | 0.089 0.063 DBMET03730 0.131 0.042 DBMET03732 | DBMET03732 | |
| 0.104 | 0.065 | 0.104 | Mediator release inhibitor | 0.103 0.067 DBMET03734 0.104 0.065 DBMET03735 | ||
| 0.079 | 0.041 | 0.12 | Purinergic P2X2 antagonist | 0.12 0.021 DBMET03731 0.097 0.032 DBMET03732 0.074 0.043 DBMET03733 0.108 0.026 DBMET03734 0.085 0.038 DBMET03735 | DBMET03731 | |
| 0.094 | 0.057 | 0.128 | Adrenaline antagonist | 0.087 0.062 DBMET03730 0.128 0.041 DBMET03732 | DBMET03732 | |
| 0.197 | 0.161 | 0.249 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.249 0.108 DBMET03731 0.224 0.131 DBMET03732 | DBMET03731 | |
| 0.13 | 0.095 | 0.135 | MAP3K9 inhibitor | 0.123 0.108 DBMET03730 0.135 0.085 DBMET03734 | DBMET03734 | |
| 0.075 | 0.042 | 0.075 | ZAP-70 protein tyrosine kinase inhibitor | 0.071 0.047 DBMET03730 0.067 0.051 DBMET03731 0.068 0.051 DBMET03734 | ||
| 0.071 | 0.04 | 0.085 | Fibroblast growth factor 2 antagonist | 0.085 0.03 DBMET03732 | DBMET03732 | |
| 0.114 | 0.083 | 0.125 | RET inhibitor | 0.125 0.076 DBMET03731 | DBMET03731 | |
| 0.094 | 0.07 | 0.103 | Insulin receptor antagonist | 0.103 0.058 DBMET03730 | DBMET03730 | |
| 0.107 | 0.085 | 0.107 | c-Src kinase inhibitor | |||
| 0.06 | 0.038 | 0.065 | Phosphatidylinositol 3-kinase delta inhibitor | 0.062 0.036 DBMET03730 0.065 0.033 DBMET03731 | DBMET03731 | |
| 0.083 | 0.061 | 0.083 | Histamine antagonist | |||
| 0.132 | 0.112 | 0.137 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.137 0.1 DBMET03731 | DBMET03731 | |
| 0.053 | 0.035 | 0.053 | Alpha 1L adrenoreceptor antagonist | |||
| 0.079 | 0.062 | 0.079 | Insulin like growth factor 1 antagonist | 0.074 0.07 DBMET03731 | ||
| 0.081 | 0.066 | 0.082 | Insulin growth factor antagonist | 0.082 0.064 DBMET03731 | DBMET03731 | |
| 0.113 | 0.1 | 0.113 | Growth factor antagonist | |||
| 0.05 | 0.038 | 0.056 | mTOR inhibitor | 0.056 0.032 DBMET03730 0.055 0.033 DBMET03731 | DBMET03730 | |
| 0.082 | 0.072 | 0.092 | Fibroblast growth factor 1 antagonist | 0.092 0.064 DBMET03731 0.082 0.072 DBMET03734 | DBMET03731 | |
| 0.086 | 0.081 | 0.086 | Alpha 2d adrenoreceptor antagonist | |||
| 0.018 | 0.014 | 0.019 | Granulocyte colony stimulating factor receptor agonist | 0.019 0.011 DBMET03731 0.018 0.015 DBMET03734 0.018 0.014 DBMET03735 | DBMET03731 | |
| 0.047 | 0.045 | 0.047 | Histamine agonist | |||
| 0.043 | 0.042 | 0.043 | Adenosine A2b receptor antagonist | |||
| 0.243 | 0.242 | 0.243 | MAP kinase 1 inhibitor | |||
| 0.065 | 0.064 | 0.095 | MAP3K7 inhibitor | 0.095 0.025 DBMET03731 | DBMET03731 | |
| 0.24 | 0.243 | 0.303 | 5 Hydroxytryptamine release inhibitor | 0.257 0.219 DBMET03731 0.302 0.163 DBMET03734 0.303 0.162 DBMET03735 | DBMET03735 | |
| 0.075 | 0.083 | 0.095 | mTOR complex 2 inhibitor | 0.095 0.039 DBMET03731 | DBMET03731 | |
| 0.044 | 0.054 | 0.052 | Alpha 1b adrenoreceptor agonist | 0.052 0.031 DBMET03731 | DBMET03731 | |
| 0.114 | 0.125 | 0.131 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.131 0.104 DBMET03732 | DBMET03732 | |
| 0.086 | 0.098 | 0.139 | Folate antagonist | 0.103 0.06 DBMET03731 0.113 0.045 DBMET03732 0.128 0.033 DBMET03734 0.139 0.027 DBMET03735 | DBMET03735 | |
| 0.078 | 0.092 | 0.091 | Phosphodiesterase 7B inhibitor | 0.091 0.069 DBMET03731 0.086 0.077 DBMET03732 0.086 0.076 DBMET03734 | DBMET03731 | |
| 0.251 | 0.266 | 0.41 | Antiinflammatory | 0.41 0.133 DBMET03731 0.335 0.184 DBMET03734 0.348 0.174 DBMET03735 | DBMET03731 | |
| 0.041 | 0.059 | 0.068 | Adenosine A1 receptor antagonist | 0.068 0.034 DBMET03731 | DBMET03731 | |
| 0.064 | 0.083 | 0.088 | Phosphodiesterase 3A inhibitor | 0.088 0.044 DBMET03730 | DBMET03730 | |
| 0.047 | 0.073 | 0.078 | Heat shock protein 90 beta antagonist | 0.078 0.022 DBMET03731 | DBMET03731 | |
| 0.125 | 0.152 | 0.194 | I kappa B kinase epsilon inhibitor | 0.194 0.076 DBMET03731 0.186 0.084 DBMET03734 | DBMET03731 | |
| 0.099 | 0.126 | 0.144 | Protein kinase (CK1) gamma 1 inhibitor | 0.144 0.074 DBMET03731 0.123 0.095 DBMET03734 | DBMET03731 | |
| 0.11 | 0.141 | 0.167 | Protein kinase (CK1) gamma 3 inhibitor | 0.167 0.072 DBMET03731 0.146 0.094 DBMET03734 | DBMET03731 | |
| 0.12 | 0.152 | 0.144 | MAP kinase kinase 4 inhibitor | 0.144 0.074 DBMET03731 0.127 0.123 DBMET03732 0.135 0.099 DBMET03734 | DBMET03731 | |
| 0.124 | 0.165 | 0.281 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.281 0.055 DBMET03731 0.17 0.114 DBMET03734 | DBMET03731 | |
| 0.093 | 0.135 | 0.15 | CDC-like kinase 1 inhibitor | 0.15 0.07 DBMET03731 | DBMET03731 | |
| 0.123 | 0.17 | 0.281 | Dyrk kinase inhibitor | 0.281 0.059 DBMET03731 0.167 0.121 DBMET03734 | DBMET03731 | |
| 0.115 | 0.162 | 0.139 | DNA methylase inhibitor | 0.139 0.127 DBMET03735 | DBMET03735 | |
| 0.079 | 0.132 | 0.142 | Glycogen synthase kinase-3 alpha inhibitor | 0.142 0.072 DBMET03731 | DBMET03731 | |
| 0.078 | 0.145 | 0.099 | CDC-like kinase 3 inhibitor | 0.097 0.087 DBMET03731 0.099 0.08 DBMET03734 | DBMET03734 | |
| 0.034 | 0.101 | 0.059 | Phosphodiesterase III inhibitor | 0.059 0.053 DBMET03730 | DBMET03730 | |
| 0.116 | 0.189 | 0.143 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.143 0.138 DBMET03732 | DBMET03732 | |
| 0.129 | 0.206 | 0.195 | Cardiotonic | 0.195 0.123 DBMET03732 0.192 0.126 DBMET03733 | DBMET03732 | |
| 0.049 | 0.126 | 0.083 | Adenosine A3 receptor antagonist | 0.083 0.04 DBMET03731 | DBMET03731 | |
| 0.037 | 0.116 | 0.058 | Transcription factor AP-1 inhibitor | 0.058 0.048 DBMET03731 | DBMET03731 | |
| 0.068 | 0.151 | 0.1 | Protein kinase (CK1) gamma 2 inhibitor | 0.1 0.083 DBMET03731 | DBMET03731 | |
| 0.096 | 0.18 | 0.171 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.171 0.101 DBMET03731 0.15 0.12 DBMET03732 0.146 0.124 DBMET03734 | DBMET03731 | |
| 0.161 | 0.246 | 0.22 | Caspase 3 stimulant | 0.22 0.143 DBMET03731 | DBMET03731 | |
| 0.091 | 0.18 | 0.128 | TRKC antagonist | 0.128 0.122 DBMET03731 | DBMET03731 | |
| 0.053 | 0.142 | 0.075 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.075 0.073 DBMET03731 | DBMET03731 | |
| 0.102 | 0.193 | 0.149 | Antimitotic | 0.149 0.122 DBMET03731 | DBMET03731 | |
| 0.074 | 0.168 | 0.117 | Protein kinase (CK1) gamma inhibitor | 0.117 0.094 DBMET03731 | DBMET03731 | |
| 0.089 | 0.185 | 0.203 | Heat shock protein 90 antagonist | 0.203 0.036 DBMET03731 | DBMET03731 | |
| 0.054 | 0.151 | 0.091 | Aminoacyl-tRNA synthetase inhibitor | 0.091 0.058 DBMET03732 0.089 0.061 DBMET03734 0.089 0.061 DBMET03735 | DBMET03732 | |
| 0.077 | 0.179 | 0.149 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.149 0.075 DBMET03731 | DBMET03731 | |
| 0.086 | 0.19 | 0.146 | Clk dual-specificity kinase inhibitor | 0.146 0.117 DBMET03731 | DBMET03731 | |
| 0.049 | 0.171 | 0.108 | Gastric antisecretory | 0.108 0.055 DBMET03732 | DBMET03732 | |
| 0.017 | 0.183 | 0.051 | Dihydrofolate reductase inhibitor | 0.051 0.018 DBMET03735 | DBMET03735 | |
| 0.05 | 0.224 | 0.096 | Interleukin 5 antagonist | 0.096 0.047 DBMET03734 | DBMET03734 | |
| 0.116 | 0.309 | 0.219 | Immunosuppressant | 0.219 0.177 DBMET03732 0.202 0.195 DBMET03734 0.209 0.188 DBMET03735 | DBMET03732 | |
| 0.035 | 0.23 | 0.127 | Polo-like kinase-4 inhibitor | 0.127 0.051 DBMET03730 | DBMET03730 | |
| 0.13 | 0.333 | 0.283 | Histamine release inhibitor | 0.238 0.164 DBMET03731 0.283 0.133 DBMET03735 | DBMET03735 | |
| 0.045 | 0.274 | 0.1 | Granulocyte macrophage colony stimulating factor agonist | 0.1 0.035 DBMET03731 | DBMET03731 | |
| 0.111 | 0.361 | 0.168 | MAP kinase kinase 5 inhibitor | 0.154 0.137 DBMET03732 0.168 0.092 DBMET03734 | DBMET03734 | |
| 0.083 | 0.374 | 0.2 | Hypoxia-inducible factor 1 alpha inhibitor | 0.2 0.152 DBMET03731 | DBMET03731 | |
| 0.048 | 0.344 | 0.165 | Heat shock protein 90 alpha antagonist | 0.165 0.073 DBMET03731 | DBMET03731 | |
| 0.074 | 0.375 | 0.244 | Transcription factor NF kappa B inhibitor | 0.244 0.132 DBMET03731 | DBMET03731 | |
| 0.033 | 0.383 | 0.073 | MAP kinase kinase 7 inhibitor | 0.073 0.068 DBMET03731 | DBMET03731 | |
| 0.091 | 0.497 | 0.193 | Nitric-oxide synthase stimulant | 0.193 0.102 DBMET03731 | DBMET03731 | |
| 0.088 | 0.509 | 0.267 | Cyclophilin D inhibitor | 0.267 0.194 DBMET03735 | DBMET03735 | |
| 0.081 | 0.593 | 0.212 | Peptidyltransferase inhibitor | 0.212 0.085 DBMET03732 | DBMET03732 | |
| 0.029 | 0.555 | 0.173 | DNA synthesis inhibitor | 0.173 0.164 DBMET03732 | DBMET03732 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |